Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yue Hu has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Jian Li

    The Orchid Conservation & Research Center of Shenzhen and the National Orchid Conservation Center of China, Shenzhen Key Laboratory for Orchid Conservation and Utilization, Key Laboratory of National Forestry and Grassland Administration on Dendrobium Officinale, Shenzhen 518114, China

    2 shared publications
  • Xiaowen Li

    The Orchid Conservation & Research Center of Shenzhen and the National Orchid Conservation Center of China, Shenzhen Key Laboratory for Orchid Conservation and Utilization, Key Laboratory of National Forestry and Grassland Administration on Dendrobium Officinale, Shenzhen 518114, China

    2 shared publications
  • Zhiyong Li

    Department of Biology, Southern University of Science and Technology, Shenzhen 518055, China

    2 shared publications
  • Demin Kong

    Shenzhen Key Laboratory for Orchid Conservation and Utilization, The National Orchid Conservation Center of China and The Orchid Conservation & Research Center of Shenzhen, Shenzhen 518114, China

    1 shared publication
  • Hai Shang

    Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100193, China

    1 shared publication
  • Jin Cheng

    State Key Laboratory of Efficient Production of Forest Resources, National Engineering Research Center of Tree Breeding and Ecological Restoration, Beijing Key Laboratory of Ornamental Plants Germplasm, Innovation and Molecular Breeding, College of Biological Sciences and Technology, Beijing Forestry University, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    Chemical Constituents, Pharmacological Activities, and Cardiovascular Protective Mechanisms of Dendrobium Species: A Review

    by Yue Hu, Zhiyong Li, Jian Li, Xiaowen Li, Meina Wang

    The genus Dendrobium, a well-known traditional Chinese medicinal herb, contains complex and diverse chemical constituents. The plant has been widely used in traditional medicine and has attracted increasing attention in modern pharmacological research due to its therapeutic potential. Bibliographic searches were conducted across various recognized databases. The exploration covered the years 1965–2025, and the connectors ‘and’ and ‘or’ were used with keywords such as “Dendrobium”, “phytochemistry”, “pharmacology”, “Cardiovascular diseases”, and “extracts”. The chemical composition of the genus Dendrobium mainly includes alkaloids, bibenzyls, flavonoids, phenanthrenes, phenylpropanoids, and terpenoids. Modern pharmacological studies have demonstrated that the genus Dendrobium exhibits multiple biological effects, including anti-tumor, antibacterial, anti-inflammatory, hypoglycemic, and neuroprotective activities. Notably, the genus Dendrobium shows significant potential in cardiovascular disease prevention and treatment through mechanisms such as antioxidant stress, anti-inflammation, regulation of lipid metabolism, anti-atherosclerosis, and inhibition of myocardial fibrosis. This review provides a comprehensive overview of the chemical components and pharmacological activities of Dendrobium plants, with emphasis on their cardiovascular protective effects. These findings offer a scientific basis for the further development and clinical application of Dendrobium medicinal resources.


  • Open Access

    Metabolomic Profiling Reveals Geographical Origin, Tissue-Specific Specialization, and Environmental Plasticity in Secondary Metabolism of Dendrobium officinale

    by Zhiyong Li, Jian Li, Yue Hu, Xinyi Wu, Xiaojuan Duan, Demin Kong, Xiaowen Li, Jin Cheng, Meina Wang

    Background/Objectives: Dendrobium officinale (D. officinale), an endangered ornamental and medicinal orchid, displays significant variability in its bioactive compounds depending on geographical and environmental factors. To decipher these influences, we investigated metabolic divergence across three cultivars (GN, LS, DX) cultivated in greenhouse and outdoor conditions using untargeted metabolomics. Methods: Metabolites extracted from stem and leaf tissues were analyzed via UHPLC-Q Exactive Orbitrap MS, and the raw data were processed using XCMS for peak alignment and quantification. Differentially abundant metabolites (DAMs) were identified by multivariate statistical analyses including PCA and OPLS-DA. Metabolic pathways were annotated using KEGG, HMDB, and LIPID Maps databases, with enrichment analysis and visualization performed via TBtools II and Hiplot. Results: Metabolite profiling and multivariate analysis revealed distinct chemotypes. The DX cultivar exhibited anthocyanin enrichment in its stems, correlating with a red pigmentation, while GN accumulated specific amino acid derivatives. Tissue-specific metabolic specialization was evident, with leaves displaying greater flavonoid diversity and stems prioritizing lipid and amino acid metabolism. Outdoor cultivation enhanced flavonoid biosynthesis, whereas greenhouse conditions favored alkaloid accumulation. Functional analysis identified both conserved pathways, like phenylpropanoid biosynthesis, and varietal-specific adaptations in amino acid and secondary metabolism. Notably, alkaloid levels declined sharply during plant defoliation. Conclusions: Our findings demonstrate that environmental factors and geographical origin synergistically shape the metabolic profiles of D. officinale. This provides a scientific basis for optimizing cultivation strategies—through targeted environmental adjustments and varietal selection—to enhance the yield of desired bioactive compounds.


  • Open Access

    The Synthesis and Biological Evaluation of Aloe-Emodin-Coumarin Hybrids as Potential Antitumor Agents

    by Hai Shang, Yue Hu, Jingrong Li, Lingyu Li, Yu Tian, Xiaoxue Li, Qi Wu, Zhongmei Zou

    A series of novel aloe-emodin–coumarin hybrids were designed and synthesized. The antitumor activity of these derivatives was evaluated against five human tumor cell lines (A549, SGC-7901, HepG2, MCF-7 and HCT-8). Some of the synthesized compounds exhibited moderate to good activity against one or more cell lines. Particularly, compound 5d exhibited more potent antiproliferative activity than the reference drug etoposide against all tested tumor cell lines, indicating that it had a broad spectrum of antitumor activity and that it may provide a promising lead compound for further development as an antitumor agent by structural modification. Furthermore, the structure–activity relationship study of the synthesized compounds was also performed.